Dow Down 0.51% Nasdaq Down 0.02%

Endocyte, Inc. (ECYT)

-NasdaqGS
7.33 Down 0.03(0.41%) 1:36PM EDT - Nasdaq Real Time Price
Prev Close:7.36
Open:7.40
Bid:7.33 x 200
Ask:7.34 x 200
1y Target Est:13.00
Beta:0.98
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:7.16 - 7.73
52wk Range:5.91 - 33.70
Volume:1,080,436
Avg Vol (3m):1,078,810
Market Cap:304.56M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECYT

Comparison

Symbol% ChgMkt Cap
ECYTDown 0.41%304.56M
NKTRUp 1.26%1.84B
RHHBYDown 0.22%247.54B
SNSSDown 1.07%447.88M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.08
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback